Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden · Delayed Price · Currency is SEK 2.850
-0.110 (-3.72%)
At close: Feb 26, 2026
Bio-Works Technologies AB Market Cap
Bio-Works Technologies AB has a market cap or net worth of 294.3 million as of February 26, 2026. Its market cap has increased by 256.13% in one year.
Market Cap
294.30M
Enterprise Value
259.36M
Revenue
63.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.85
Market Cap Chart
Since December 14, 2017, Bio-Works Technologies AB's market cap has increased from 241.45M to 294.30M, an increase of 21.89%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 294.30M | 14.36% |
| Dec 30, 2025 | 257.35M | 242.79% |
| Dec 30, 2024 | 75.08M | -72.87% |
| Dec 29, 2023 | 276.76M | -62.42% |
| Dec 30, 2022 | 736.44M | -23.21% |
| Dec 30, 2021 | 959.03M | 246.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 508.87M |
| Corline Biomedical AB | 390.61M |
| Ascelia Pharma AB | 386.32M |
| Elicera Therapeutics AB | 304.32M |
| Lipum AB | 295.91M |
| Mendus AB | 293.55M |
| Xintela AB | 241.15M |
| Sprint Bioscience AB | 234.24M |